Three distinct myeloid subsets were defined based on differential marker expression: Myeloid 1 cells exhibited low CD11b, Ly6G, CD11c, and f4/80 with intermediate Ly6C and high MHC-II, consistent with inflammatory monocytes or immature monocytic cells; Myeloid 2 cells expressed low levels of Ly6C and MHC-II with intermediate Ly6G, CD11c, CD11b, and F4/80, indicative of tumor-associated macrophages (TAMs) or differentiated macrophages; and Myeloid 3 cells demonstrated high CD11c, MHC-II, CD11b, Ly6C, Ly6G, and F4/80 consistent with antigen-presenting dendritic-like cells. This evidence concerns the gene ITGAX and neoplasm.